Angioedema following venipuncture in a patient on angiotensin-converting enzyme inhibitor and dipeptidyl peptidase-IV inhibitor therapy: A case report

被引:0
|
作者
Benic, Adrien [1 ]
Boyard, Adrien [1 ,2 ]
Pogossian, Alexan [3 ]
Misery, Laurent [1 ,2 ]
Roguedas-Contios, Anne-Marie [1 ,2 ]
机构
[1] Univ Hosp Brest, Dept Dermatol Venereol & Allergy, 2 Ave Foch, F-29200 Brest, France
[2] Univ Brest, Lab Interact Epitheliums Neurones, Brest, France
[3] Univ Hosp Brest, Dept Internal Med & Pulmonol, Brest, France
来源
关键词
acquired angioedema; angiotensin-converting enzyme inhibitors; bradykinin; dipeptidyl-peptidase IV inhibitors; wounds and injuries; HEREDITARY;
D O I
10.1002/jvc2.582
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Acquired angioedema (AAE) is a rare, potentially life-threatening condition, primarily induced by medications, with attacks typically triggered by major trauma. We report a rare case of AAE triggered locally by minor trauma-a forearm venipuncture-in a 77-year-old male taking ramipril and sitagliptin. The venipuncture and these medications acted synergistically through distinct pathways in bradykinin metabolism, resulting in localized AAE. This case highlights the importance of recognizing minor trauma as a potential trigger in patients on multiple AAE-inducing medications.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] A Rare Case of Visceral Angioedema Secondary to Angiotensin-Converting Enzyme Inhibitor
    Khan, Simin
    Rashid, Shazia
    Pandit, Sudha
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2599 - S2599
  • [32] Effects of Dipeptidyl Peptidase-4 Inhibitor and Angiotensin-Converting Enzyme Inhibitor on Experimental Diabetic Kidney Disease
    Al Tuhaifi, Tareq
    Zhong, Jianyong
    Yang, Hai-Chun
    Fogo, Agnes B.
    LABORATORY INVESTIGATION, 2024, 104 (02)
  • [33] Perioperative angioedema in a patient on long-term angiotensin-converting enzyme (ACE)-inhibitor therapy
    Ogbureke, KUE
    Cruz, C
    Johnson, JV
    Helfrick, JF
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1996, 54 (07) : 917 - 920
  • [34] Angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibitor-induced angioedema: A disproportionality analysis of the WHO pharmacovigilance database
    Lepelley, Marion
    Khouri, Charles
    Lacroix, Clemence
    Bouillet, Laurence
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (07): : 2406 - +
  • [35] Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema
    Brown, Nancy J.
    Byiers, Stuart
    Carr, David
    Maldonado, Mario
    Warner, Barbara Ann
    HYPERTENSION, 2009, 54 (03) : 516 - U141
  • [36] The development of angioedema in a patient with type 2 diabetes due to a novel dipeptidyl peptidase-IV inhibitor, anagliptin
    Hamasaki, Hidetaka
    Yanai, Hidekatsu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : E106 - E106
  • [37] Different patterns of angioedema in patients with and without angiotensin-converting enzyme inhibitor therapy
    Herkner, H
    Temmel, AF
    Müllner, M
    Havel, C
    Hirschl, MM
    Kofler, J
    Laggner, AN
    WIENER KLINISCHE WOCHENSCHRIFT, 2001, 113 (5-6) : 167 - 171
  • [38] In silico and in vitro analysis of dipeptidyl peptidase-IV and angiotensin-converting enzyme inhibitory peptides derived milk lactoferrin
    Elisha, Cherise
    Bhagwat, Prashant
    Pillai, Santhosh
    INTERNATIONAL DAIRY JOURNAL, 2025, 160
  • [39] Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Case Report With a Review of Management Options
    Ameer, Muhammad Atif
    Mushtaq, Javaria
    Chaudhry, Haroon
    Patel, Nimi
    Khan, Somia Ilyas
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [40] Angiotensin-converting enzyme inhibitor induced angioedema. New therapy options
    Bas, M.
    Kojda, G.
    Stelter, K.
    ANAESTHESIST, 2011, 60 (12): : 1141 - +